On Thursday shares of FibroGen, Inc. (NASDAQ:FGEN) closed at $23.86. FibroGen, Inc. (NASDAQ:FGEN) announced that it has received a $15 million milestone payment from AstraZeneca AB (“AstraZeneca”), triggered by the completion of roxadustat non-clinical carcinogenicity studies. In two separate two-year carcinogenicity studies, in rats and in mice, there was no evidence of a roxadustat-related effect on mortality or carcinogenicity.
Immunomedics Inc. (NASDAQ:IMMU) in last trading activity increased 2.43% to close at $3.80. Company weekly performance is 5.56% while its quarterly performance stands at -5.24%. Immunomedics Inc. (NASDAQ:IMMU) is -30.66% away from its 52 week high. On 6 May, Immunomedics Inc. (NASDAQ:IMMU) reported financial results for the third quarter ended March 31, 2015. Total costs and expenses for the current quarter were $12.3 million, as compared to $10.7 million for the same period in 2014, representing an increase of $1.6 million or 15%.
On last trading day Southwestern Energy Co. (NYSE:SWN) decreased -2.50% to close at $27.34. Its volatility for the week is 3.47% while volatility for the month is 3.60%. SWN’s sales growth for past 5 years was 13.50% and its EPS growth for past 5 years was 95.00%. Southwestern Energy Co. (NYSE:SWN) monthly performance is 13.44%. Southwestern Energy Co. (NYSE:SWN) said that, it is tossing around the idea of building an operating base in southwestern Pennsylvania’s shale fields.
Voya Financial, Inc. (NYSE:VOYA) has 0.20% insider ownership while its institutional ownership stands at 89.80%. In last trading activity company’s stock closed at $43.95. On 6 May, Voya Financial, Inc. (NYSE:VOYA) reported total revenues of $2.63 billion for the quarter, down from $2.67 billion during the same three months in 2014. Net realized capital losses were up to $265 million, from $191 million a year earlier. Revenue from fees during the quarter was down to $899.8 million from $931.8 million in 2014. Revenue from investments and premiums were up.
On last trading day Healthcare Trust of America, Inc. (NYSE:HTA) increased 0.44% to close at $25.12. Its volatility for the week is 2.06% while volatility for the month is 1.77%. HTA’s sales growth for past 5 years was 23.50% and its EPS growth for past 5 years was 23.20%. Healthcare Trust of America, Inc. (NYSE:HTA) monthly performance is -9.54%. On 6 May, Healthcare Trust of America, Inc. (NYSE:HTA) announced results for the quarter ended March 31, 2015. Rental income increased 8.8% to $98.5 million for the three months ended March 31, 2015, compared to $90.5 million for the three months ended March 31, 2014. The increase in rental income was primarily driven by $474.8 million of acquisitions since March 31, 2014, together with Same-Property growth.